Skip to main content
Log in

Quantitative computed tomography assessment for systemic sclerosis–related interstitial lung disease: comparison of different methods

  • Chest
  • Published:
European Radiology Aims and scope Submit manuscript

Abstract

Objectives

To compare the previously defined six different histogram-based quantitative lung assessment (QLA) methods on high-resolution CT (HRCT) in patients with systemic sclerosis (SSc)–related interstitial lung disease (ILD).

Methods

The HRCT images of SSc patients with ILD were reviewed, and the visual ILD score (semiquantitative) and the severity of ILD (limited or extensive) were calculated. The QLA score of ILD was evaluated using the previously defined six different methods and parameters (different lung attenuation ranges, skewness, kurtosis, mean lung attenuation, and standard deviation [SD]). Pulmonary function tests (PFTs) were also performed on all patients. Relationships among variables were evaluated using Spearman’s correlation coefficient (r). Diagnostic performance of quantitative methods for the ability to differentiate the limited from extensive ILD was calculated using ROC analysis.

Results

Fifty-five patients were included in the study. There was a significant correlation between all quantitative and semiquantitative measurement results (p < 0.0001). The QLA scores revealed a significant correlation with PFT results. The kurtosis value of the voxels between − 200 and − 1024 Hounsfield unit (HU) (Method-5) showed the best correlation with semiquantitative evaluation (r = − 0.740, p < 0.0001). The ROC analysis demonstrated the best performance of SD of the voxels between − 400 and − 950 HU (Method-6) for histogram analysis method and Method-3 (voxels between − 260 and − 600 HU were calculated as ILD) for CT density cutoff methods.

Conclusions

All the QLA methods are applicable in assessing the ILD score in SSc patients and have potential importance to differentiate limited from extensive ILD.

Key Points

• Quantitative interstitial lung disease assessment helps clinicians to assess systemic sclerosis patients with interstitial lung disease.

• Quantitative lung assessment methods are applicable in assessing the interstitial lung disease score in systemic sclerosis patients.

• Quantitative lung assessment methods have potential importance in the management of patients.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5

Similar content being viewed by others

Abbreviations

AUC:

Area under the curve

CII:

Computerized integrated index

CII-5:

Computerized integrated index of Method-5

CII-6:

Computerized integrated index of Method-6

CT:

Computed tomography

CVDs:

Collagen vascular diseases

DLCO:

Single-breath diffusing capacity

DcSSc:

Diffuse forms of systemic sclerosis

FEV1:

Forced expiratory volume in 1 s

FVC:

Forced vital capacity

HRCT:

High-resolution computed tomography

HU:

Hounsfield unit

ILD:

Interstitial lung disease

KURT-5:

Kurtosis value of Method-5

KURT-6:

Kurtosis value of Method-6

LcSSc:

Limited forms of systemic sclerosis

MLA:

Mean lung attenuation

MLA-5:

Mean lung attenuation value of Method-5

MLA-6:

Mean lung attenuation value of Method-6

PCA:

Principal component analysis

PFT:

Pulmonary function test

PRoTA:

Pattern recognition or texture analysis

QLA:

Quantitative lung assessment

QUANT-1:

Quantitative Method-1

QUANT-2:

Quantitative Method-2

QUANT-3:

Quantitative Method-3

QUANT-4:

Quantitative Method-4

ROC:

Receiver operating characteristic

SD:

Standard deviation

SD-5:

Standard deviation value of Method-5

SD-6:

Standard deviation value of Method-6

SKEW-5:

Skewness value of Method-5

SKEW-6:

Skewness value of Method-6

SSc:

Systemic sclerosis

TLC:

Total lung capacity

References

  1. Walker UA, Tyndall A, Czirjak L et al (2007) Clinical risk assessment of organ manifestations in systemic sclerosis: a report from the EULAR Scleroderma Trials and Research group database. Ann Rheum Dis 66:754–763

    Article  CAS  Google Scholar 

  2. Steen VD, Medsger TA (2007) Changes in causes of death in systemic sclerosis, 1972-2002. Ann Rheum Dis 66:940–944

    Article  Google Scholar 

  3. Ioannidis JP, Vlachoyiannopoulos PG, Haidich AB et al (2005) Mortality in systemic sclerosis: an international meta-analysis of individual patient data. Am J Med 118:2–10

    Article  Google Scholar 

  4. Mouthon L, Berezné A, Brauner M, Kambouchner M, Guillevin L, Valeyre D (2007) Pneumopathie infiltrante diffuse de la sclerodermie systemique [Interstitial lung disease in systemic sclerosis]. Rev Mal Respir 24:1035–1046

  5. Caron M, Hoa S, Hudson M, Schwartzman K, Steele R (2018) Pulmonary function tests as outcomes for systemic sclerosis interstitial lung disease. Eur Respir Rev 27:170102

  6. Watadani T, Sakai F, Johkoh T et al (2013) Interobserver variability in the CT assessment of honeycombing in the lungs. Radiology 266:936–944

    Article  Google Scholar 

  7. Aziz ZA, Wells AU, Hansell DM et al (2004) HRCT diagnosis of diffuse parenchymal lung disease: inter-observer variation. Thorax 59:506–511

    Article  CAS  Google Scholar 

  8. Ninaber MK, Stolk J, Smit J et al (2015) Lung structure and function relation in systemic sclerosis: application of lung densitometry. Eur J Radiol 84:975–979

    Article  Google Scholar 

  9. Yabuuchi H, Matsuo Y, Tsukamoto H et al (2014) Evaluation of the extent of ground-glass opacity on high-resolution CT in patients with interstitial pneumonia associated with systemic sclerosis: comparison between quantitative and qualitative analysis. Clin Radiol 69:758–764

    Article  CAS  Google Scholar 

  10. Salaffi F, Carotti M, Bosello S et al (2015) Computer-aided quantification of interstitial lung disease from high resolution computed tomography images in systemic sclerosis: correlation with visual reader-based score and physiologic tests. Biomed Res Int 2015:834262

    PubMed  PubMed Central  Google Scholar 

  11. Salaffi F, Carotti M, Di Donato E, Di Carlo M, Ceccarelli L, Giuseppetti G (2016) Computer-aided tomographic analysis of interstitial lung disease (ILD) in patients with systemic sclerosis (SSc). Correlation with pulmonary physiologic tests and patient-centred measures of perceived dyspnea and functional disability. PLoS One 11:e0149240

    Article  Google Scholar 

  12. Marten K, Dicken V, Kneitz C et al (2009) Interstitial lung disease associated with collagen vascular disorders: disease quantification using a computer-aided diagnosis tool. Eur Radiol 19:324–332

    Article  CAS  Google Scholar 

  13. Marten K, Dicken V, Kneitz C et al (2009) Computer-assisted quantification of interstitial lung disease associated with rheumatoid arthritis: preliminary technical validation. Eur J Radiol 72:278–283

    Article  CAS  Google Scholar 

  14. Çetinçakmak MG, Göya C, Hamidi C et al (2016) Quantitative volumetric assessment of pulmonary involvement in patients with systemic sclerosis. Quant Imaging Med Surg 6:50–56

    PubMed  PubMed Central  Google Scholar 

  15. Ariani A, Silva M, Bravi E et al (2015) Operator-independent quantitative chest computed tomography versus standard assessment of interstitial lung disease related to systemic sclerosis: a multi-centric study. Mod Rheumatol 25:724–730

    Article  Google Scholar 

  16. Ariani A, Lumetti F, Silva M et al (2014) Systemic sclerosis interstitial lung disease evaluation: comparison between semiquantitative and quantitative computed tomography assessments. J Biol Regul Homeost Agents 28:507–513

    CAS  PubMed  Google Scholar 

  17. Camiciottoli G, Orlandi I, Bartolucci M et al (2007) Lung CT densitometry in systemic sclerosis: correlation with lung function, exercise testing, and quality of life. Chest 131:672–681

    Article  Google Scholar 

  18. Koyama H, Ohno Y, Yamazaki Y et al (2010) Quantitatively assessed CT imaging measures of pulmonary interstitial pneumonia: effects of reconstruction algorithms on histogram parameters. Eur J Radiol 74:142–146

    Article  Google Scholar 

  19. Kazantzi A, Costaridou L, Skiadopoulos S et al (2014) Automated 3D ιnterstitial lung disease extent quantification: performance evaluation and correlation to PFTs. J Digit Imaging 27:380–391

    Article  Google Scholar 

  20. Kim HJ, Brown MS, Elashoff R et al (2011) Quantitative texture-based assessment of one-year changes in fibrotic reticular patterns on HRCT in scleroderma lung disease treated with oral cyclophosphamide. Eur Radiol 21:2455–2465

    Article  Google Scholar 

  21. Kim HJ, Tashkin DP, Gjertson DW et al (2016) Transitions to different patterns of interstitial lung disease in scleroderma with and without treatment. Ann Rheum Dis 75:1367–1371

    Article  CAS  Google Scholar 

  22. Kim HG, Tashkin DP, Clements PJ et al (2010) A computer-aided diagnosis system for quantitative scoring of extent of lung fibrosis in scleroderma patients. Clin Exp Rheumatol 28:S26–S35

    CAS  PubMed  PubMed Central  Google Scholar 

  23. Jacob J, Bartholmai BJ, Rajagopalan S et al (2016) Evaluation of computer-based computer tomography stratification against outcome models in connective tissue disease-related interstitial lung disease: a patient outcome study. BMC Med 14:190

    Article  Google Scholar 

  24. Khanna D, Nagaraja V, Tseng CH et al (2015) Predictors of lung function decline in scleroderma-related interstitial lung disease based on high-resolution computed tomography: implications for cohort enrichment in systemic sclerosis-associated interstitial lung disease trials. Arthritis Res Ther 17:372

    Article  Google Scholar 

  25. Tashkin DP, Volkmann ER, Tseng CH et al (2016) Relationship between quantitative radiographic assessments of interstitial lung disease and physiological and clinical features of systemic sclerosis. Ann Rheum Dis 75:374–381

    Article  CAS  Google Scholar 

  26. Rosas IO, Yao J, Avila NA, Chow CK, Gahl WA, Gochuico BR (2011) Automated quantification of high-resolution CT scan findings in individuals at risk for pulmonary fibrosis. Chest 140:1590–1597

    Article  Google Scholar 

  27. van den Hoogen F, Khanna D, Fransen J et al (2013) 2013 classification criteria for systemic sclerosis: an American College of Rheumatology/European League against rheumatism collaborative initiative. Ann Rheum Dis 72:1747–1755

    Article  Google Scholar 

  28. Miller MR, Hankinson J, Brusasco V et al (2005) Standardisation of spirometry. Eur Respir J 26:319–338

    Article  CAS  Google Scholar 

  29. Goh NS, Desai SR, Veeraraghavan S et al (2008) Interstitial lung disease in systemic sclerosis: a simple staging system. Am J Respir Crit Care Med 177:1248–1254

    Article  Google Scholar 

  30. Zhang Z, Castelló A (2017) Principal components analysis in clinical studies. Ann Transl Med 5:351

    Article  Google Scholar 

  31. Warrick JH, Bhalla M, Schabel SI, Silver RM (1991) High resolution computed tomography in early scleroderma lung disease. J Rheumatol 18:1520–1528

    CAS  PubMed  Google Scholar 

  32. Winstone TA, Assayag D, Wilcox PG et al (2014) Predictors of mortality and progression in scleroderma-associated interstitial lung disease: a systematic review. Chest 146:422–436

    Article  Google Scholar 

  33. Ariani A, Silva M, Seletti V et al (2017) Quantitative chest computed tomography is associated with two prediction models of mortality in interstitial lung disease related to systemic sclerosis. Rheumatology (Oxford) 56:922–927

    Article  Google Scholar 

  34. Bocchino M, Bruzzese D, D’Alto M et al (2019) Performance of a new quantitative computed tomography index for interstitial lung disease assessment in systemic sclerosis. Sci Rep 9:9468

    Article  Google Scholar 

Download references

Acknowledgments

The authors thank Dr. Hande Senol for help in statistical analyses.

Funding

The authors state that this work has not received any funding.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Furkan Ufuk.

Ethics declarations

Guarantor

The scientific guarantor of this publication is Furkan UFUK, MD.

Conflict of interest

The authors of this manuscript declare no relationships with any companies whose products or services may be related to the subject matter of the article.

Statistics and biometry

Dr. Hande Senol kindly provided statistical advice for this manuscript.

Informed consent

Written informed consent was waived by the Institutional Review Board.

Ethical approval

Institutional Review Board approval was obtained.

Methodology

• Retrospective

• Cross sectional study

• Performed at one institution

Additional information

Publisher’s note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Electronic supplementary material

ESM 1

(DOCX 16 kb)

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Ufuk, F., Demirci, M. & Altinisik, G. Quantitative computed tomography assessment for systemic sclerosis–related interstitial lung disease: comparison of different methods. Eur Radiol 30, 4369–4380 (2020). https://doi.org/10.1007/s00330-020-06772-2

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00330-020-06772-2

Keywords

Navigation